The FDA has approved Gazyva (obinutuzumab) as an add-on treatment for adults with lupus nephritis, Genentech said.

What is Gazyva for lupus nephritis? Gazyva (obinutuzumab) is a medication approved in the U.S. for adults with active lupus nephritis who are receiving standard therapies. The treatment is given via ...

Relief from lupus pain can be seen as a placeholder, not unlike that moment before a great discovery, writes columnist ...

ADI-001 led to reductions in disease activity for seven lupus patients in a clinical trial, with no serious side effects reported, data show.

Protecting your energy is crucial in life with chronic illness, says columnist Marisa Zeppieri, so be sure to avoid things that drain you.

During a random conversation, a family member, one of the smartest little humans in my life, told me about the books she’s been reading. One is nonfiction and the other is young adult fantasy. She was ...

A self-administered, under-the-skin injection version of AstraZeneca’s Saphnelo (anifrolumab-fnia) was effective for reducing disease severity in adults with systemic lupus erythematosus (SLE), ...

As months turn into years and years turn into decades of living with systemic lupus erythematosus, we begin to record what helps mitigate or temper symptoms before they turn into a full-blown flare.

“If you don’t answer to anyone, you will start lying to yourself,” a financial consultant once explained to me. His wisdom, albeit a bit sharp in tone, transcended his focus on money management into ...

May is Lupus Awareness Month, and for several reasons, Fred Rogers and his eponymous children’s program “Mister Rogers’ Neighborhood” are on my mind. Fifty-six years ago this month, Mr. Rogers ...

If, like me, you have a chronic illness, have you ever sat with the thought that maybe you did something to cause it? I certainly have. Over the years, I’ve noticed that many conversations I’ve had ...

The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to FT819, a cell therapy Fate Therapeutics is developing to treat lupus. An RMAT ...